NGVT250117C75000
- 0.00
- 0.000.00%
インジェビティのニュース一覧
Is Ingevity (NGVT) Stock Undervalued Right Now?
Does Ingevity (NYSE:NGVT) Have A Healthy Balance Sheet?
Ingevity Elects Kevin Willis to Its Board of Directors
Ingevity Corporation (NGVT): The Small Cap Chemical Stock Hedge Funds Are Watching Closely
Here's Why You Should Retain Mosaic Stock in Your Portfolio
Here's Why You Should Hold Onto Air Products Stock for Now
Why Is Ingevity (NGVT) Up 14.6% Since Last Earnings Report?
CF Industries Shares Scale 52-Week High: What's Driving the Stock?
SouthernSun Small Cap Strategy Is Evaluating Its Position in Ingevity Corporation (NGVT) Amid Strategic Changes and Management Transitions
Should Value Investors Buy Ingevity (NGVT) Stock?
Ingevity Price Target Raised to $47.00/Share From $40.00 by BMO Capital
Ingevity Is Maintained at Market Perform by BMO Capital
Ingevity Analyst Ratings
Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript Summary
インジェビティ | 10-Q：Q3 2024 四半期報告書
Ingevity Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Adjusted EPS Results.
Ingevity (NYSE:NGVT) Adds US$109m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 61%
BMOキャピタル・マーケッツはインジェビティ(NGVT.US)のレーティングを中立に据え置き、目標株価を40ドルに引き下げた
BMOキャピタル・マーケッツのアナリストJohn McNultyは$Ingevity(NGVT.US)$のレーティングを中立に据え置き、目標株価を42ドルから40ドルに引き下げた。TipRanksのデータによると、このアナリストの最近1年間の的中率は53.3%、平均リターンは2.9%である。注 TipRanksは、金融アナリストの分析データと、アナリストの的中率および平均リターンに関する情報を提供
Ingevity: Q3 Earnings Snapshot
インジェビティ | 8-K：インゲビティ、2024年第3四半期の決算を発表